Clinical Trial Update: Chemotherapy Plus Ofatumumab Followed by G-CSF for Mobilization of Peripheral Blood Stem Cells in Patients With Non-Hodgkin's Lymphomas [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing chemotherapy plus ofatumumab followed by G-CSF for mobilizing peripheral blood stem cells in patients with non-Hodgkin's lympho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Chemotherapy (chemotherapy)
• Granulocyte Colony Stimulating Factor (granulocyte colony-stimulating factor (G-CSF))
• Ofatumumab (ofatumumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2020-07-08